LGD-3303, also known as LGD3303, is a selective androgen receptor modulator (SARM) that has been developed for its potential medical applications in the treatment of muscle-wasting diseases such as sarcopenia and cachexia. Along with LGD-3303, another SARM called GW0742 or Gw-0742 is also gaining popularity in the fitness industry for its fat-burning and endurance-enhancing effects. In this article, we will explore both of these compounds and their potential benefits, mechanisms, safety, and dosing information.
Chemical Name:
LGD-3303: 9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one
GW0742: 2-(4-((2-(4-(Trifluoromethyl)phenyl)-5-methylthiazol-4-yl)methylthio)phenoxy)acetic acid
Molecular Formula:
LGD-3303: C16H14ClF3N2O
GW0742: C21H17F3N2O3S
Formula Weight:
LGD-3303: 342.74 g/mol
GW0742: 460.43 g/mol
CAS No:
LGD-3303: 1196133-39-7
GW0742: 317318-84-6
Top Ten Keywords and Synonyms:
Health Benefits of LGD-3303 and GW0742:
LGD-3303 has been shown to improve muscle mass and strength in animal studies, without causing the negative effects on prostate and seminal vesicles seen with testosterone use. It is also being studied for its potential to treat osteoporosis and other bone-related disorders. However, human studies are limited, and more research is needed to fully understand its effects.
GW0742, on the other hand, is primarily used for its fat-burning and endurance-enhancing effects. It increases fatty acid oxidation and glucose uptake in skeletal muscles, leading to greater endurance during exercise. It has also been shown to reduce inflammation and oxidative stress in animal studies.
Potential Effects of LGD-3303 and GW0742:
LGD-3303 has been shown to increase muscle mass and strength in animal studies, although its effects in humans are not well-established. It may also have potential applications in treating osteoporosis and other bone-related disorders.
GW0742 is primarily used for its fat-burning and endurance-enhancing effects. It has been shown to increase fatty acid oxidation and glucose uptake in skeletal muscles, leading to greater endurance during exercise. It may also have anti-inflammatory and antioxidant properties.
Product Mechanism:
LGD-3303 selectively binds to the androgen receptor in muscle and bone tissue, leading to increased muscle mass and bone density. It does not bind to the androgen receptor in other tissues such as the prostate and seminal vesicles, potentially avoiding the negative side effects associated with testosterone use.
GW0742 activates peroxisome proliferator-activated receptor delta (PPARδ), a protein that regulates energy metabolism and fatty acid oxidation. This leads to increased fatty acid and glucose uptake in skeletal muscles, as well as greater endurance during exercise.
Safety:
The long-term safety of LGD-3303 and GW0742 is not well-established, as there have been few human studies conducted. Animal studies have shown some potential risks, including liver toxicity and changes in lipid levels. As with all supplements and drugs, it is important to consult with a healthcare professional before use.
Side Effects:
Some potential side effects of LGD-3303 and GW0742 include headache, nausea, and changes in liver function. More serious side effects, such as heart attack and stroke, cannot be ruled out. It is important to monitor for any adverse reactions and to discontinue use if any occur.
Dosing Information:
The optimal dosing for LGD-3303 and GW0742 is not well-established, as there have been few human studies conducted. Some recommended dosages for LGD-3303 range from 5-15mg/day, while GW0742 dosages typically range from 5-20mg/day. However, it is important to consult with a healthcare professional before use to determine the appropriate dosage based on individual needs and goals
